OSU6162 15 mg

DRUG2 trials

Sponsors

University Of Gothenburg

Conditions

Bipolar depressionDepression

Phase 2

OSU6162 as add-on in SSRI/SNRI-resistant depression (ODEN): a double-blind, placebo-controlled evaluation of efficacy and safety

Not yet recruitingCTIS2024-513894-35-00

University Of GothenburgDepression

Target: 180Updated: 2024-10-25

OSU6162 in Bipolar Depression: An Open-label, Flexible Dose Study (OBID)

Not yet recruitingCTIS2024-517560-30-00

University Of GothenburgBipolar depression

Target: 22Updated: 2024-10-28